Search results
Found 34 matches for
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
©
John Cairns
Advancing a malaria vaccine for better global health outcomes
Department General Public Engagement
20 March 2024
Professor Sue Ann Costa Clemens CBE, Chair of Global Health at the Department of Paediatrics and Head of Oxford Latam Research Group – a collaboration between Oxford and Brazil, aimed at strengthening our commitment to global health – met with His Excellency Antonio Patriota, Brazilian Ambassador to the UK, to discuss the co-development of a Malaria vaccine and advance public health outcomes in Brazil.
New trial to study how the human immune system adapts to ‘tolerate’ malaria parasites
Department Methods Public Engagement Research
18 March 2024
Scientists at the University of Oxford and the University of Edinburgh have launched a pioneering study that examines how the immune system responds to repeated malaria infections. The BIO-004 study is being run in partnership between the Department of Biochemistry (Draper Lab, based in the Kavli Institute for Nanoscience Discovery), the University of Edinburgh (Spence Lab, Institute of Immunology and Infection Research) and the Oxford Vaccine Group (part of the Department of Paediatrics). BIO-004 will provide a unique insight into how the immune system adapts over the first few malaria infections of life, learning to tolerate malaria parasites and developing natural immunity to severe illness.
FCDO Minister meets with vaccine researchers
Department Public Engagement Research
25 January 2024
Researchers from the Department of Paediatrics today welcomed the Rt Hon Andrew Mitchell MP, Minister for Development and Africa, to the laboratories and clinics of several of its vaccine development groups.
New campaign hopes to boost jab numbers
COVID-19 Methods Parents and Carers Public Engagement
8 December 2023
Experts have launched a new campaign in a bid to boost waning vaccine uptake by giving people more information about how clinical trials work. Researchers hope to alleviate hesitancy by showing with a simple animation and comic the complex way vaccines are developed.
Oxford launches new vaccine trial to enhance design of flu & COVID-19 vaccines
COVID-19 Methods Public Engagement Research
25 October 2023
A pioneering study into human immunity is being launched today by Oxford Vaccine Group at the University of Oxford. The study, called LEGACY03, is being funded by the Medical Research Council part of UK Research and Innovation. By investigating how lymph nodes work, and how they make responses to vaccines in younger and older people, it has the potential to improve vaccine design for different age groups significantly.
Future of Chair in Global Health secured with £5 million gift
Awards & Appointments Department Public Engagement
20 September 2023
The University of Oxford’s commitment to tackling major global health challenges has been strengthened following the endowment of a chair in global health and clinical development. The new permanent post was made possible by a £5 million donation from Brazilian healthcare organisation SAIL for Health.
First vaccine trial in older people launched for Middle East Respiratory Syndrome (MERS)
COVID-19 Methods Public Engagement Research
18 September 2023
Researchers at the University of Oxford's Pandemic Sciences Institute have launched a new clinical trial to find a vaccine to protect people against Middle East Respiratory Syndrome (MERS).
First in-human trials commence for CCHF vaccine
COVID-19 Methods Public Engagement Research
13 September 2023
A University of Oxford study has administered a new vaccine against tick-borne virus Crimean-Congo haemorrhagic fever (CCHF) to human volunteers for the first time. The clinical trial of the ChAdOx2 CCHF vaccine aims to confirm its safety and understand how individuals develop immunity following vaccination.
University of Oxford partners with CEPI to counter the threat of future pandemics
COVID-19 Department Public Engagement Research
30 August 2023
The University of Oxford and the Coalition for Epidemic Preparedness Innovations (CEPI) have entered into a strategic partnership to accelerate the development of safe, effective and globally accessible vaccines to counter the threat of future pandemics.
Professor Sir Andrew Pollard reveals unique insights into the world of science in a new podcast
Public Engagement
28 April 2023
Oxford Vaccine Group and Pandemic Sciences Institute’s Professor Pollard speaks to the people who shaped the COVID-19 pandemic in his new podcast, The Oxford Colloquy.
COVID-19 vaccine messaging that focuses on personal benefits is most effective with those who are hesitant
COVID-19 Public Engagement
14 May 2021
For the one in ten who say they won’t take a COVID-19 vaccine, messaging that focuses on personal rather than collective benefits is more effective.
How do nucleic acid vaccines work?
Public Engagement
13 May 2021
Ever wondered what happens inside your cells when you are infected with a virus? Or wondered how the new COVID-19 vaccines work? The answer to both of these questions can be found in how our cells receive instructions to make proteins. Actually, our cells are a bit like factories...
Increasing vaccine uptake among ethnic minorities
COVID-19 Public Engagement
6 May 2021
Dr Samantha Vanderslott and Dr Seilesh Kadambari discuss their collaborative approach to providing ethnic minority groups with information on vaccines.
COVID-19: how to tackle vaccine hesitancy among BAME groups
COVID-19 Public Engagement
19 March 2021
Samantha Vanderslott, Andrew Pollard and Seilesh Kadambari discuss vaccine uptake among Black, Asian and minority ethnic communities in an article for The Conversation.
Oxford vaccine researchers talk research and home-schooling on ITV's This Morning
COVID-19 Public Engagement
7 January 2021
Professor Katie Ewer (The Jenner Institute) and Dr Maheshi Ramasamy (Oxford Vaccine Group) appeared on ITV's This Morning on Wednesday 6 January to talk about their work developing the ChAdOx1 nCoV-19 coronavirus vaccine, all while juggling the demands of young families and home-schooling.
Award for OVG's learning games
Awards & Appointments Public Engagement
19 November 2020
Learning games explaining the links between typhoid, sewage systems and food hygiene have won the gold prize at the Learning Technologies Awards 2020.
Alice in Typhoidland wins film trophy
Awards & Appointments Public Engagement
15 June 2020
Bristol Science Film Festival awarded the Professional Science Fact Film Prize to "The Adventures of Alice in Typhoidland" co-created by the Oxford Vaccine Group.
Alice in Typhoidland: Join Lewis Carroll’s Alice on a journey through the story of typhoid, from Victorian sewer systems to cutting-edge scientific research
Public Engagement
20 January 2020
A new exhibition tells the story of Oxford’s role in the fight against typhoid, from pioneering efforts to eliminate typhoid in the era of Lewis Carroll’s Alice in Wonderland to game-changing present-day vaccine trials.
Is mandatory vaccination the best way to tackle falling rates of childhood immunisation?
Public Engagement
28 October 2019
Following the publication of figures showing UK childhood vaccination rates have fallen for the fifth year in a row, researchers from OVG and the Oxford Martin Programme on Collective Responsibility for Infectious Disease discuss possible responses.
Paediatrics celebrates International Clinical Trials Day
Public Engagement
20 May 2019
Sign up to take part in our clinical trials, talk to the research staff, or simply enjoy a Microbe Mugshot Match or a Game of Crohn's (Disease).